Name: A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage (Video) | JoVE Journal
Uploaded: 2022-04-28T14:45:00.000+00:00
Duration: 4 min 25 s
Description: Learn to establish a chlorhexidine gluconate-induced peritoneal fibrosis mouse model for peritoneal dialysis research. This simple, visible protocol helps researchers study pathological changes and improve PD therapy outcomes.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

We sincerely thank Shin-Han Tseng for the critical discussion and partial execution of the study. This study was supported by EDAHP110003 and NCKUEDA110002 from the Research Foundation of E-DA Hospital and the National Cheng Kung University, Taiwan.

All mouse experiments were approved by the Laboratory Animal Center of the E-DA Hospital/ I-Shou University and were handled according to the "Guide for the Care and Use of Laboratory Animals" (NRC, USA 2011). Male C57BL/6 mice, 7-8 weeks old, were used for the present study.
1. Chemical preparation
<ol>
	<li>Prepare the chemical irritant by diluting 0.1% chlorhexidine gluconate (CG, see Table of Materials) in 15% ethanol.</li>
</ol>
2. Animal treatment
<ol>
	<li>Assign three mice as the control group. Perform intraperitoneal injection (i.p.) of 1 mL/kg of 0.9% normal saline (NS) every other day for 3 weeks, for a total of nine times.</li>
	<li>Assign three mice to the peritoneal fibrosis group. Induce peritoneal fibrosis using chlorhexidine gluconate (CG) by administering i.p. injections of 0.1% of CG in 15% ethanol (step 1.1) at a dose of 12.5 µL/g body weight. Perform this every other day for 3 weeks, for a total of nine times.</li>
</ol>
3. Peritoneal function tests (modified peritoneal equilibration test)
<ol>
	<li>Prepare a dialysis solution containing 4.25% glucose. Draw 0.5 mL of dialysate sample with a syringe, and then check the glucose concentration in the dialysate sample. 
	NOTE: The glucose concentration is determined according to the hexokinase/G6PD method. Dialysate samples were accessed to L-type Glu 2 assay and investigated with a biochemical analyzer (see Table of Materials). This is the initial dialysate glucose concentration.</li>
	<li>Anesthetize the mice by intramuscular injection of Zoletil and Xylazine (prepared in a ratio of 1:2 by volume, see Table of Materials) at a dose of 20 µL/20 gw. Additionally, use vet ointment on the eyes to prevent dryness under anesthesia.</li>
	<li>Perform i.p. instillation of the dialysis solution (2 mL/20 g bodyweight).</li>
	<li>After 30 min, assess and verify the depth of anesthesia with lack of toe pinch reflex. Then, perform a vertical incision in the midline of the abdominal (beneath the xiphoid process), then open the mice's abdomen and collect the intraperitoneal fluid with a syringe (defined as "volume 1"). Then, measure the weight of a clean and dry cotton and put the cotton into the mice's abdominal cavity to absorb the residual intraperitoneal fluid. Finally, measure the cotton weight again. 
	NOTE: The weight gain of cotton is equal to the weight of the residual intraperitoneal fluid. Then, convert to the obtained volume (specific gravity: 1 g/cm3; defined as "volume 2"). The final dialysate volume is volume 1 plus volume 2.</li>
	<li>Use 0.5 mL of dialysate sample (final dialysate) to measure the glucose concentration. This is the final dialysate glucose concentration.</li>
	<li>Calculate the net ultrafiltration using the formula15: 
	<img alt="Dialysis volume ratio equation diagram, showing volume change in dialysis setup for concentration analysis." src="/files/ftp_upload/63903/63903eq01.jpg" style="margin: auto;" data-altupdatedat="1788282455000" data-alt="Equation 1"></li>
	<li>Calculate the peritoneal permeability using the following formula15: 
	<img alt="Glucose concentration change formula in dialysis; equation for concentration and volume difference." src="/files/ftp_upload/63903/63903eq02.jpg" style="margin: auto;" data-altupdatedat="1788282455000" data-alt="Equation 2"></li>
</ol>
4. Tissue preparation of the abdominal wall muscle and liver and histological analysis
<ol>
	<li>Sacrifice the mice via cardiac puncture (phlebotomy)3,16.</li>
	<li>Cut the abdominal wall (1 cm x 1 cm) and total hepatectomy. Fix the mice's abdominal wall and liver tissues overnight in 10% neutral buffered formalin.</li>
	<li>Prepare 3 µm thick paraffin sections of the abdominal wall muscle and liver, and perform histological analysis following previously published report17.</li>
	<li>Evaluate the parietal peritoneum of the abdominal wall and visceral peritoneum of the liver surfaces of the mice using morphometry18.</li>
	<li>Perform statistical analyses using statistics and graphing software (see Table of Materials). Express all data as mean ± SD and analyze for statistical significance using a t-test19. Define values with P &lt; 0.05 as significant results.</li>
</ol>

<ol><li>Han, S. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Improving+outcome+of+CAPD%3A+twenty-five+years%27+experience+in+a+single+Korean+center%5BTitle%5D)+AND+%22Peritoneal+Dialysis+International%22%5BJournal%5D)">Improving outcome of CAPD: twenty-five years' experience in a single Korean center.</a> Peritoneal Dialysis International. 27 (4), 432-440 (2007).</li>
<li>Kawaguchi, Y., Hasegawa, T., Nakayama, M., Kubo, H., Shigematu, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Issues+affecting+the+longevity+of+the+continuous+peritoneal+dialysis+therapy%5BTitle%5D)+AND+%22Kidney+International+Supplements%22%5BJournal%5D)">Issues affecting the longevity of the continuous peritoneal dialysis therapy.</a> Kidney International Supplements. 62, 105-107 (1997).</li>
<li>Lee, Y. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Vitamin+D+can+ameliorate+chlorhexidine+gluconate-induced+peritoneal+fibrosis+and+functional+deterioration+through+the+inhibition+of+epithelial-to-mesenchymal+transition+of+mesothelial+cells%5BTitle%5D)+AND+%22BioMed+Research+International%22%5BJournal%5D)">Vitamin D can ameliorate chlorhexidine gluconate-induced peritoneal fibrosis and functional deterioration through the inhibition of epithelial-to-mesenchymal transition of mesothelial cells.</a> BioMed Research International. 2015, 595030(2015).</li>
<li>Nakamoto, H., Kawaguchi, Y., Suzuki, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Is+technique+survival+on+peritoneal+dialysis+better+in+Japan%5BTitle%5D)+AND+%22Peritoneal+Dialysis+International%22%5BJournal%5D)">Is technique survival on peritoneal dialysis better in Japan.</a> Peritoneal Dialysis International. 26 (2), 136-143 (2006).</li>
<li>Schaefer, F., Klaus, G., Muller-Wiefel, D. E., Mehls, O. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Current+practice+of+peritoneal+dialysis+in+children%3A+results+of+a+longitudinal+survey.+Mid+European+Pediatric+Peritoneal+Dialysis+Study+Group+%28MEPPS%29%5BTitle%5D)+AND+%22Peritoneal+Dialysis+International%22%5BJournal%5D)">Current practice of peritoneal dialysis in children: results of a longitudinal survey. Mid European Pediatric Peritoneal Dialysis Study Group (MEPPS).</a> Peritoneal Dialysis International. 19, Suppl 2 445-449 (1999).</li>
<li>Woodrow, G., Turney, J. H., Brownjohn, A. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Technique+failure+in+peritoneal+dialysis+and+its+impact+on+patient+survival%5BTitle%5D)+AND+%22Peritoneal+Dialysis+International%22%5BJournal%5D)">Technique failure in peritoneal dialysis and its impact on patient survival.</a> Peritoneal Dialysis International. 17 (4), 360-364 (1997).</li>
<li>Schmidt, D. W., Flessner, M. F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Pathogenesis+and+treatment+of+encapsulating+peritoneal+sclerosis%3A+basic+and+translational+research%5BTitle%5D)+AND+%22Peritoneal+Dialysis+International%22%5BJournal%5D)">Pathogenesis and treatment of encapsulating peritoneal sclerosis: basic and translational research.</a> Peritoneal Dialysis International. 28, Suppl 5 10-15 (2008).</li>
<li>Augustine, T., Brown, P. W., Davies, S. D., Summers, A. M., Wilkie, M. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Encapsulating+peritoneal+sclerosis%3A+clinical+significance+and+implications%5BTitle%5D)+AND+%22Nephron+Clinical+Practice%22%5BJournal%5D)">Encapsulating peritoneal sclerosis: clinical significance and implications.</a> Nephron Clinical Practice. 111 (2), 149-154 (2009).</li>
<li>Di Paolo, N., Nicolai, G. A., Garosi, G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+peritoneum%3A+from+histological+studies+to+mesothelial+transplant+through+animal+experimentation%5BTitle%5D)+AND+%22Peritoneal+Dialysis+International%22%5BJournal%5D)">The peritoneum: from histological studies to mesothelial transplant through animal experimentation.</a> Peritoneal Dialysis International. 28, Suppl 5 5-9 (2008).</li>
<li>Fusshoeller, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Histomorphological+and+functional+changes+of+the+peritoneal+membrane+during+long-term+peritoneal+dialysis%5BTitle%5D)+AND+%22Pediatric+Nephrology%22%5BJournal%5D)">Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis.</a> Pediatric Nephrology. 23 (1), 19-25 (2008).</li>
<li>Goffin, E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Peritoneal+membrane+structural+and+functional+changes+during+peritoneal+dialysis%5BTitle%5D)+AND+%22Seminars+in+Dialysis%22%5BJournal%5D)">Peritoneal membrane structural and functional changes during peritoneal dialysis.</a> Seminars in Dialysis. 21 (3), 258-265 (2008).</li>
<li>Ito, T., Yorioka, N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Peritoneal+damage+by+peritoneal+dialysis+solutions%5BTitle%5D)+AND+%22Clinical+and+Experimental+Nephrology%22%5BJournal%5D)">Peritoneal damage by peritoneal dialysis solutions.</a> Clinical and Experimental Nephrology. 12 (4), 243-249 (2008).</li>
<li>Io, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((SAHA+suppresses+peritoneal+fibrosis+in+mice%5BTitle%5D)+AND+%22Peritoneal+Dialysis+International%22%5BJournal%5D)">SAHA suppresses peritoneal fibrosis in mice.</a> Peritoneal Dialysis International. 35 (3), 246-258 (2015).</li>
<li>Yoh, K., Ojima, M., Takahashi, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Th2-biased+GATA-3+transgenic+mice+developed+severe+experimental+peritoneal+fibrosis+compared+with+Th1-biased+T-bet+and+Th17-biased+RORgammat+transgenic+mice%5BTitle%5D)+AND+%22Experimental+Animals%22%5BJournal%5D)">Th2-biased GATA-3 transgenic mice developed severe experimental peritoneal fibrosis compared with Th1-biased T-bet and Th17-biased RORgammat transgenic mice.</a> Experimental Animals. 64 (4), 353-362 (2015).</li>
<li>Karl, Z. J. T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Peritoneal+Equilibration+Test%5BTitle%5D)+AND+%22Peritoneal+Dialysis+International%22%5BJournal%5D)">Peritoneal Equilibration Test.</a> Peritoneal Dialysis International. 7 (3), 138-148 (1987).</li>
<li>Lee, Y. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+clinical+implication+of+vitamin+D+nanomedicine+for+peritoneal+dialysis-related+peritoneal+damage%5BTitle%5D)+AND+%22International+Journal+of+Nanomedicine%22%5BJournal%5D)">The clinical implication of vitamin D nanomedicine for peritoneal dialysis-related peritoneal damage.</a> International Journal of Nanomedicine. 14, 9665-9675 (2019).</li>
<li>Goldner, J. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Modification+of+the+masson+trichrome+technique+for+routine+laboratory+purposes%5BTitle%5D)+AND+%22The+American+Journal+of+Pathology%22%5BJournal%5D)">Modification of the masson trichrome technique for routine laboratory purposes.</a> The American Journal of Pathology. 14 (2), 237-243 (1938).</li>
<li>Cheng, F. Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Novel+application+of+magnetite+nanoparticle-mediated+vitamin+D3+delivery+for+peritoneal+dialysis-related+peritoneal+damage%5BTitle%5D)+AND+%22International+Journal+of+Nanomedicine%22%5BJournal%5D)">Novel application of magnetite nanoparticle-mediated vitamin D3 delivery for peritoneal dialysis-related peritoneal damage.</a> International Journal of Nanomedicine. 16, 2137-2146 (2021).</li>
<li>Ross, A., Willson, V. L. <a target="_blank" href="http://scholar.google.com/scholar?hl=en&safe=off&q=author%3aRoss%2C+A+%22Basic+and+Advanced+Statistical+Tests%3A+Writing+Results+Sections+and+Creating+Tables+and+Figures%22">Basic and Advanced Statistical Tests: Writing Results Sections and Creating Tables and Figures</a>. , SensePublishers. 13-16 (2017).</li>
<li>Suga, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Preventive+effect+of+pirfenidone+against+experimental+sclerosing+peritonitis+in+rats%5BTitle%5D)+AND+%22Experimental+and+Toxicologic+Pathology%22%5BJournal%5D)">Preventive effect of pirfenidone against experimental sclerosing peritonitis in rats.</a> Experimental and Toxicologic Pathology. 47 (4), 287-291 (1995).</li>
<li>Ishii, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((An+experimental+sclerosing+encapsulating+peritonitis+model+in+mice%5BTitle%5D)+AND+%22Nephrology+Dialysis+Transplantation%22%5BJournal%5D)">An experimental sclerosing encapsulating peritonitis model in mice.</a> Nephrology Dialysis Transplantation. 16 (6), 1262-1266 (2001).</li>
<li>Nishino, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Antisense+oligonucleotides+against+collagen-binding+stress+protein+HSP47+suppress+peritoneal+fibrosis+in+rats%5BTitle%5D)+AND+%22Kidney+International%22%5BJournal%5D)">Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress peritoneal fibrosis in rats.</a> Kidney International. 64 (3), 887-896 (2003).</li>
<li>Mishima, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Enhanced+expression+of+heat+shock+protein+47+in+rat+model+of+peritoneal+fibrosis%5BTitle%5D)+AND+%22Peritoneal+Dialysis+International%22%5BJournal%5D)">Enhanced expression of heat shock protein 47 in rat model of peritoneal fibrosis.</a> Peritoneal Dialysis International. 23 (1), 14-22 (2003).</li>
<li>Kushiyama, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Effects+of+liposome-encapsulated+clodronate+on+chlorhexidine+gluconate-induced+peritoneal+fibrosis+in+rats%5BTitle%5D)+AND+%22Nephrology+Dialysis+Transplantation%22%5BJournal%5D)">Effects of liposome-encapsulated clodronate on chlorhexidine gluconate-induced peritoneal fibrosis in rats.</a> Nephrology Dialysis Transplantation. 26 (10), 3143-3154 (2011).</li>
<li>Nishino, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Involvement+of+lymphocyte+infiltration+in+the+progression+of+mouse+peritoneal+fibrosis+model%5BTitle%5D)+AND+%22Renal+Failure%22%5BJournal%5D)">Involvement of lymphocyte infiltration in the progression of mouse peritoneal fibrosis model.</a> Renal Failure. 34 (6), 760-766 (2012).</li>
<li>Lua, I., Li, Y., Pappoe, L. S., Asahina, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Myofibroblastic+conversion+and+regeneration+of+mesothelial+cells+in+peritoneal+and+liver+fibrosis%5BTitle%5D)+AND+%22The+American+Journal+of+Pathology%22%5BJournal%5D)">Myofibroblastic conversion and regeneration of mesothelial cells in peritoneal and liver fibrosis.</a> The American Journal of Pathology. 185 (12), 3258-3273 (2015).</li>
<li>Kitamura, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Epigallocatechin+gallate+suppresses+peritoneal+fibrosis+in+mice%5BTitle%5D)+AND+%22Chemico-Biological+Interactions%22%5BJournal%5D)">Epigallocatechin gallate suppresses peritoneal fibrosis in mice.</a> Chemico-Biological Interactions. 195 (1), 95-104 (2012).</li>
</ol>

The authors have nothing to disclose.

In this study, a mouse PD model is presented by i.p. injection of CG, and the results showed peritoneal fibrosis and functional deterioration in this model, which mimicked the PD patient&#39;s condition.
There are several critical steps in the protocol. First, for performing an i.p. injection of CG or NS, the abdominal wall skin of the mouse must be picked up using forceps to prevent puncture-induced intraperitoneal organ damage. Second, while collecting the peritoneum of the abdominal wall fo...

Peritoneal dialysis (PD) is a type of renal replacement therapy. However, PD has problems that cannot be solved. For example, long-term PD treatment can cause peritoneal damage, eventually leading to ultrafiltration failure and withdrawal of treatment1,2,3,4,5,6. Peritoneal fibrosis is one of the most serious complications7,8. Peritoneal fibrosis is characterized by the deposition and accumulation of extracellular matrix within the interstitium, and neo-angiogenesis and vasculopathy of the peritoneum9,10.
The main causes of these peritoneal changes are recurrent peritonitis and non-biocompatibility of the dialysate, which are hyperosmotic, high glucose, low pH, and glucose degradation product accumulation11,12. Therefore, suitable animal experimental models can help researchers better study the peritoneum&#39;s physiological and pathological changes during PD therapy. Therefore, establishing an animal PD model is important for improving PD technology and dialysis efficacy and prolonging patient survival. This study aimed to generate a PD mouse model by intraperitoneal (i.p.) injection of chlorhexidine gluconate (CG), as described previously13,14. This PD mouse model is simple, easy to use, and feasible compared to other PD animal models.

<table><tbody><tr><td>0.9% Normal Saline</td><td>Y F CHEMICAL CORP., New Taipei City, Taiwan</td><td>-</td><td></td></tr><tr><td>10% neutral buffered formalin</td><td>Taiwan Burnett International Co., Ltd., Taipei City, Taiwan</td><td>00002A</td><td></td></tr><tr><td>Automatic biochemical analyzer</td><td>Hitachi Ltd., Tokyo, Japan</td><td>Labospect Series 008</td><td>for determining glucose concentration</td></tr><tr><td>Chlorhexidine digluconate solution, 20% in H&lt;sub&gt;2&lt;/sub&gt;O</td><td>Sigma-Aldrich, MO, USA</td><td>C9394</td><td>diluted to 0.1% with 15% ethanol for injection</td></tr><tr><td>Ethanol</td><td>Avantor Performance Materials, LLC, PA, USA</td><td>BAKR8006-05</td><td>diluted to 15% with normal saline for working concentration</td></tr><tr><td>Glucose (Dianeal)</td><td>Baxter International, Inc., IL, USA</td><td>FNB9896</td><td>Commercial dialysis solution (4.25%)</td></tr><tr><td>GraphPad Prism 8.0</td><td>GraphPad Software, Inc., CA, US</td><td></td><td></td></tr><tr><td>L-type Glu 2 assay</td><td>FUJIFILM Wako, Japan</td><td>461-32403</td><td></td></tr><tr><td>Xylazine 20</td><td>Juily Pharmaceutical Co., Ltd., New Taipei City, Taiwan</td><td>-</td><td></td></tr><tr><td>Zoletil 50</td><td>Virbac Laboratories, Carros, France</td><td>-</td><td></td></tr></tbody></table>

a mice model of chlorhexidine gluconate-induced peritoneal damage

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage

Peritoneal fibrosis is an important complication of peritoneal dialysis (PD). To investigate and address this problem, an appropriate animal model of PD is required. The present protocol establishes a chlorhexidine gluconate (CG) induced peritoneal fibrosis model that mimics the condition of a patient with PD. Peritoneal fibrosis was induced by intraperitoneal injection of 0.1% of CG in 15% ethanol for 3 weeks (administered every other day), for a total of nine times in male C57BL/6 mice. Peritoneal functional tests were then performed on day 22. After the mice were sacrificed, the parietal peritoneum of the abdominal wall and the visceral peritoneum of the liver were harvested. They were thicker and more fibrotic when analyzed microscopically after Masson's trichrome staining. The ultrafiltration rate decreased, and glucose mass transport indicated a CG-induced increase in peritoneal permeability. The PD model thus established may have applications in improving PD technology, dialysis efficacy, and prolonging patient survival.

In Figure 1A,B, the parietal peritoneum of the abdominal wall was markedly thicker and more fibrotic under Masson's trichrome staining17, indicating that in the CG-exposed group, peritoneal fibrosis is more severe than in the control saline group (NS). In Figure 2A,B, the visceral peritoneum of the liver surfaces was also markedly thicker and more fibrotic, thus proving that in the CG-exposed group, perit...

The present protocol establishes a peritoneal dialysis (PD) mouse model of chlorhexidine gluconate (CG)-induced peritoneal fibrosis. The current model is simple and easy to use compared to other PD animal models.

Peritoneal fibrosis is an important complication of peritoneal dialysis (PD). To investigate and address this problem, an appropriate animal model of PD ...

a-mice-model-of-chlorhexidine-gluconate-induced-peritoneal-damage

Research

JoVE Journal

Medicine

Source: de Vries, C. R., et.al. A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection. J. Vis. Exp. (2020)This video demonstrates the delayed inoculation of luminescent Pseudomonas aeruginosa into a mouse bearing two full-thickness dorsal skin wounds covered by a transparent film dressing. This facilitates biofilm formation and the establishment of chronic infection. Regular bioluminescence monitoring enables quantification of bacterial burden and tracking of infection...

Developing a Mouse Model of Chronic Pseudomonas aeruginosa Skin Wound Infection 

Here we describe a novel diabetic murine model utilizing hairless mice for real-time, non-invasive, monitoring of biofilm wound infections of bioluminescent Pseudomonas aeruginosa. This method can be adapted to evaluate infection of other bacterial species and genetically modified microorganisms, including multi-species biofilms, and test the efficacy of antibiofilm strategies.

Come to the Light Side: In Vivo Monitoring of Pseudomonas aeruginosa Biofilm Infections in Chronic Wounds in a Diabetic Hairless Murine Model

This article shows the method for the surgical placement in mice of an intraperitoneal catheter attached to an access port that is positioned at the back of the animal. Moreover, it explains the procedure for a 5/6 nephrectomy to resemble the uremic state of PD patients.

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

There is an update associated with this article. Please click here to see the update. Chronic wounds are developed from acute wounds on a diabetic mouse model by inducing high levels of oxidative stress after a full-thickness cutaneous wound. The wound is treated with inhibitors for catalase and glutathione peroxidase, resulting in impaired healing and biofilm development by bacteria present in the skin microbiome.

Protocol to Create Chronic Wounds in Diabetic Mice

Here, we present a protocol to locally induce apical periodontitis in mice. We show how to drill a hole in the mouse's tooth and expose its pulp, in order to cause local inflammation. Analysis methods to investigate the nature of this inflammation, such as micro-CT and histology, are also demonstrated.

Inducing Apical Periodontitis in Mice

The present protocol describes a standardized surgical method for the elastase-induced AAA model through the direct application of elastase to the adventitia of infrarenal abdominal aorta in mice.

Mouse Abdominal Aortic Aneurysm Model Induced by Perivascular Application of Elastase

This article describes modifications of a procedure to implant a peritoneal dialysis catheter in a murine model to avoid major technical issues observed with the conventional techniques.

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

This study presents two crucial experimental techniques: the construction of a murine wound model for assessing wound closure and the preparation of single-cell suspensions from murine skin to preserve cellular viability.

Mouse Wound Models and Preparation of Single-Cell Suspensions

This manuscript presents a protocol for establishing a mouse abdominal aortic aneurysm model using calcium chloride and elastase, combining the advantages of previous modeling methods. This model can be utilized to investigate the pathophysiological mechanisms underlying abdominal aortic aneurysms.

A Mouse Abdominal Aortic Aneurysm Model by Periadventitial Calcium Chloride and Elastase Infiltration

Intraperitoneal drug administration is a safe and effective non-invasive approach for inducing pancreatic injury. This study compared five distinct intraperitoneal injection protocols on mice to induce varying degrees of pancreatic injury and established a model of severe pancreatic injury to investigate the pathological changes and treatment strategies for severe acute pancreatitis (SAP).

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Learn to establish a chlorhexidine gluconate-induced peritoneal fibrosis mouse model for peritoneal dialysis research. This simple, visible protocol helps researchers study pathological changes and improve PD therapy outcomes.

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage

Explore More Videos